Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy

Splice-switching antisense oligonucleotides are emerging treatments for neuromuscular diseases, with several splice-switching oligonucleotides (SSOs) currently undergoing clinical trials such as for Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA). However, the development of syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabanpoor, Fazel, Hammond, Suzan M, Abendroth, Frank, Hazell, Gareth, Wood, Matthew J.A., Gait, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467147/
https://www.ncbi.nlm.nih.gov/pubmed/28118087
http://dx.doi.org/10.1089/nat.2016.0652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467147/
https://www.ncbi.nlm.nih.gov/pubmed/28118087
http://dx.doi.org/10.1089/nat.2016.0652

Ejemplares similares